Cannabinoid manufacturers have less than a week to submit data and comments to U.S. health regulators considering whether to allow extracts such as CBD into foods and dietary supplements.
Deadline nears to weigh in on FDA cannabinoid supplement review is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read the full article here
